Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects
Creator
Bates, Matthew
Mwaba, Peter
Zumla, Alimuddin
Drosten, Christian
Al-Hakeem, Rafaat
Breuer, Judy
Gant, Vanya
Gautret, Philippe
Gray, Gregory
Hui, David
Kidd, Mike
Maeurer, Markus
Memish, Ziad
Al-Rabeeah, Abdullah
Al-Tawfi, A
Muller, Marcel
Source
Elsevier; Medline; PMC
abstract
Respiratory tract infections rank second as causes of adult and paediatric morbidity and mortality worldwide. Respiratory tract infections are caused by many different bacteria (including mycobacteria) and viruses, and rapid detection of pathogens in individual cases is crucial in achieving the best clinical management, public health surveillance, and control outcomes. Further challenges in improving management outcomes for respiratory tract infections exist: rapid identification of drug resistant pathogens; more widespread surveillance of infections, locally and internationally; and global responses to infections with pandemic potential. Developments in genome amplification have led to the discovery of several new respiratory pathogens, and sensitive PCR methods for the diagnostic work-up of these are available. Advances in technology have allowed for development of single and multiplexed PCR techniques that provide rapid detection of respiratory viruses in clinical specimens. Microarray-based multiplexing and nucleic-acid-based deep-sequencing methods allow simultaneous detection of pathogen nucleic acid and multiple antibiotic resistance, providing further hope in revolutionising rapid point of care respiratory tract infection diagnostics.
has issue date
2014-09-01
(
xsd:dateTime
)
bibo:doi
10.1016/s1473-3099(14)70827-8
bibo:pmid
25189349
has license
no-cc
sha1sum (hex)
fb1e6c6515b467e7fb1c0d0e0e5a76a681a3f180
schema:url
https://doi.org/10.1016/s1473-3099%2814%2970827-8
resource representing a document's title
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects
has PubMed Central identifier
PMC7106435
has PubMed identifier
25189349
schema:publication
Lancet Infect Dis
resource representing a document's body
covid:fb1e6c6515b467e7fb1c0d0e0e5a76a681a3f180#body_text
is
schema:about
of
named entity 'potential'
named entity 'caused'
named entity 'internationally'
named entity 'control'
named entity 'locally'
named entity 'respiratory tract'
named entity 'bacterial'
named entity 'BACTERIAL'
named entity 'PATHOGEN'
named entity 'DIAGNOSTICS'
named entity 'CHALLENGES'
named entity 'HAVE'
named entity 'MULTIPLE'
named entity 'GLOBAL'
named entity 'MYCOBACTERIA'
named entity 'PATHOGENS'
named entity 'CLINICAL'
named entity 'CATION'
named entity 'LED'
named entity 'DIAGNOSTIC'
named entity 'DISCOVERY'
named entity 'SIMULTANEOUS'
named entity 'NUCLEIC ACID'
named entity 'VIRUSES'
named entity 'POTENTIAL'
named entity 'ALLOW'
named entity 'SURVEILLANCE'
named entity 'DEVELOPMENT'
named entity 'IMPROVING'
named entity 'GENOME'
named entity 'HOPE'
named entity 'MORBIDITY AND MORTALITY'
named entity 'CLINICAL MANAGEMENT'
named entity 'PUBLIC HEALTH SURVEILLANCE'
named entity 'PROVIDE'
named entity 'WORK-UP'
named entity 'TECHNIQUES'
named entity 'EXIST'
named entity 'NEEDS'
named entity 'RESPIRATORY TRACT INFECTIONS'
named entity 'POINT OF CARE'
named entity 'SENSITIVE'
named entity 'SEQUENCING'
covid:arg/fb1e6c6515b467e7fb1c0d0e0e5a76a681a3f180
named entity 'CONTROL'
named entity 'RESPIRATORY TRACT INFECTION'
named entity 'RESPONSES'
named entity 'PANDEMIC'
named entity 'MULTIPLEXING'
named entity 'POINT OF CARE'
named entity 'ADULT'
named entity 'WORLDWIDE'
named entity 'PAEDIATRIC'
named entity 'DEEP'
named entity 'SPECIMENS'
named entity 'CAUSES'
named entity 'NEW'
named entity 'SECOND'
named entity 'CASES'
named entity 'TECHNOLOGY'
named entity 'VIRAL AND'
named entity 'BACTERIA '
named entity 'RAPID'
named entity 'DIAGNOSTIC TESTS'
named entity 'FUTURE'
named entity 'WIDESPREAD'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 8
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software